Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank.
Martel A, Gastaud L, Bonnetaud C, Nahon-Esteve S, Washetine K, Bordone O, Salah M, Tanga V, Fayada J, Lespinet V, Allegra M, Lalvee S, Zahaf K, Baillif S, Bertolotto C, Mograbi B, Lassalle S, Hofman P. Martel A, et al. Among authors: zahaf k. Cancers (Basel). 2023 Apr 19;15(8):2372. doi: 10.3390/cancers15082372. Cancers (Basel). 2023. PMID: 37190299 Free PMC article. Review.
[Accreditation of the activity of molecular pathology according to ISO 15189: key steps to follow and the main potential pitfalls].
Long E, Hofman V, Ilie M, Washetine K, Lespinet V, Bonnetaud C, Bordone O, Gavric-Tanga V, Gaziello MC, Lassalle S, Selva E, Zahaf K, Lamy A, Sabourin JC, Hofman P. Long E, et al. Among authors: zahaf k. Ann Pathol. 2013 Feb;33(1):12-23. doi: 10.1016/j.annpat.2012.11.004. Epub 2013 Jan 30. Ann Pathol. 2013. PMID: 23472892 French.
[Setting up a department of molecular pathology in oncology in a pathology laboratory (LPCE, CHU de Nice)].
Long E, Hofman V, Ilie M, Lespinet V, Bonnetaud C, Bordone O, Gavric-Tanga V, Washetine K, Gaziello MC, Mauro V, Lassalle S, Selva E, Zahaf K, Santini J, Castillo L, Lacour JP, Vénissac N, Mouroux J, Otto J, Poudenx M, Marquette CH, Sabourin JC, Hofman P. Long E, et al. Among authors: zahaf k. Ann Pathol. 2013 Feb;33(1):24-37. doi: 10.1016/j.annpat.2012.12.003. Epub 2013 Jan 30. Ann Pathol. 2013. PMID: 23472893 French.
[The accreditation of a surgical pathology and somatic genetic laboratory (LPCE, CHU of Nice) according to the ISO 15189 norm: Sharing of experience].
Washetine K, Long E, Hofman V, Lassalle S, Ilie M, Lespinet V, Bonnetaud C, Bordone O, Gavric-Tanga V, Selva E, Reverso-Meinietti J, Sadoulet D, Lacour L, Bille Y, Lavagna R, Grier P, Zahaf K, Mari M, Hofman P. Washetine K, et al. Among authors: zahaf k. Ann Pathol. 2013 Dec;33(6):386-97. doi: 10.1016/j.annpat.2013.10.002. Epub 2013 Nov 14. Ann Pathol. 2013. PMID: 24331720 French.
Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.
Ilie M, Long-Mira E, Funck-Brentano E, Lassalle S, Butori C, Lespinet-Fabre V, Bordone O, Gay A, Zahaf K, Poissonnet G, Lacour JP, Bahadoran P, Ballotti R, Gros A, Dutriaux C, Saiag P, Merlio JP, Vergier B, Emile JF, Hofman V, Hofman P. Ilie M, et al. Among authors: zahaf k. J Am Acad Dermatol. 2015 May;72(5):786-93. doi: 10.1016/j.jaad.2015.01.012. Epub 2015 Feb 7. J Am Acad Dermatol. 2015. PMID: 25659223
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies.
Ilie M, Long-Mira E, Bence C, Butori C, Lassalle S, Bouhlel L, Fazzalari L, Zahaf K, Lalvée S, Washetine K, Mouroux J, Vénissac N, Poudenx M, Otto J, Sabourin JC, Marquette CH, Hofman V, Hofman P. Ilie M, et al. Among authors: zahaf k. Ann Oncol. 2016 Jan;27(1):147-53. doi: 10.1093/annonc/mdv489. Epub 2015 Oct 19. Ann Oncol. 2016. PMID: 26483045 Free article.
PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome.
Ilie M, Falk AT, Butori C, Chamorey E, Bonnetaud C, Long E, Lassalle S, Zahaf K, Vénissac N, Mouroux J, Cohen C, Brambilla E, Marquette CH, Hofman V, Hofman P. Ilie M, et al. Among authors: zahaf k. Mod Pathol. 2016 Dec;29(12):1552-1564. doi: 10.1038/modpathol.2016.149. Epub 2016 Aug 26. Mod Pathol. 2016. PMID: 27562497 Free article.
Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.
Falk AT, Yazbeck N, Guibert N, Chamorey E, Paquet A, Ribeyre L, Bence C, Zahaf K, Leroy S, Marquette CH, Cohen C, Mograbi B, Mazières J, Hofman V, Brest P, Hofman P, Ilié M. Falk AT, et al. Among authors: zahaf k. Lung Cancer. 2018 Jul;121:70-75. doi: 10.1016/j.lungcan.2018.05.009. Epub 2018 May 26. Lung Cancer. 2018. PMID: 29858030
Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.
Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage AL, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette CH, Sabourin JC, Ilié M, Hofman P. Hofman V, et al. Among authors: zahaf k. J Thorac Oncol. 2019 Jul;14(7):1204-1212. doi: 10.1016/j.jtho.2019.03.024. Epub 2019 Apr 15. J Thorac Oncol. 2019. PMID: 30999109 Free article.
21 results